How should pharmaceutical enterprises transform and upgrade with the continuous deepening of volume purchasing?

[pharmaceutical network industry trends] in recent years, under the heavy combination of "4 + 7" volume procurement, medical insurance catalog adjustment and other medical insurance control fees, pharmaceutical companies are more and more aware of the new era of medicine is coming In particular, with the continuous deepening of volume purchase, in addition to the price and water of many drugs being squeezed out, the process of industry shuffling has also begun to accelerate In view of the above situation, enterprises urgently need to achieve "breakthrough" through transformation and upgrading But transformation and upgrading is not an easy thing, and there are many noteworthy points Therefore, according to the opinions of the industry, the author summarizes four suggestions to share with you Focus on advantageous business At present, the global large pharmaceutical enterprises are in the stage of strengthening their core competitiveness From the transfer of production lines of many multinational pharmaceutical enterprises this year, we can see that they are all accelerating the focus on advantageous business and divestiture of non advantageous business, so as to form an effective brand separation and competitive separation Therefore, under the great reshuffle of the industry, Chinese pharmaceutical enterprises should also focus on advantageous businesses if they want to successfully transform and upgrade However, it should be noted that focusing on advantageous business is not necessarily to only operate a specific disease field, but to form one or several major disease fields Of course, how to implement it depends on which one the enterprise thinks can better widen the gap with its competitors Improve efficiency in all aspects Nowadays, the profound changes in the pharmaceutical industry environment are making the pharmaceutical industry step into a new stage of high quality, high speed and innovative development This makes the traditional pharmaceutical enterprises have to speed up the promotion of production and operation efficiency, to achieve successful business transformation In terms of improving production efficiency, at present, many pharmaceutical enterprises have paid attention to the promotion of pharmaceutical equipment in the production process, started to actively upgrade equipment, and paid close attention to the "efficiency" problem by improving the technical gold content of equipment For example, after a pharmaceutical enterprise uses the intelligent production equipment of truking technology, the original batch of pharmaceutical production takes about 4 days, now it only takes 12 hours, greatly improving the production efficiency, reducing many costs for the enterprise Carry out innovative research and development according to their ability Pharmaceutical enterprises are the main body of the development of pharmaceutical industry With the change of situation and policy, innovation has become a necessary means for the development of many pharmaceutical enterprises In the future, only with the original research and innovation medicine as the center, can we support the long-term development of the enterprise But in fact, not all enterprises are suitable for innovation For those leading enterprises, it is a wise choice to speed up the research and development of innovative drugs and strive for early access to volume procurement For some small pharmaceutical companies without research and development capabilities, it may be a more realistic choice to transform to big health or other surrounding industries as soon as possible We should provide good service Ma Yun, the founder of Alibaba, said in a speech at the fourth Chu business conference that the real economy is modern manufacturing plus modern service industry, which cannot be opposed to manufacturing Manufacturing should learn from service industry The pharmaceutical industry is also a manufacturing industry While attaching importance to the quality of drugs and increasing innovation and research and development, we should also improve the quality of after-sales service, bring higher added value to users, so as to have stronger competitiveness At present, in addition to the traditional after-sales service, many pharmaceutical companies have developed a large number of personalized services to meet customer needs Among them, Lunan pharmaceutical has made more detailed services with the help of Internet development express, including launching flagship stores successively in Jingdong and tmall, independently establishing the public health service website "at the beginning of health" and more than ten interactive self media platforms At the same time of providing fine and accurate services for customers, it is also gradually opening up the path of brand to high-end.